NewsBenzingaEvercore ISI Group Maintains Outperform on Mirum Pharmaceuticals, Raises Price Target to $146 Evercore ISI Group Maintains Outperform on Mirum Pharmaceuticals, Raises Price Target to $146 Benzinga 2026.10.13 17:51 (GMT+0) Open on Benzinga Other news Earnings Preview: What to Expect From Mosaic’s Report Gartner’s Q3 2026 Earnings: What to Expect Global Payments’ Quarterly Earnings Preview: What You Need to Know Earnings Preview: What to Expect From Assurant Report What a New Nvidia-Backed AI Platform Means for Honeywell Stock What You Need to Know Ahead of Yum! Brands' Earnings Release
